Breaking News

West Completes Second Manufacturing Plant in China

Expands presence in Asia-Pacific region

West Pharmaceutical Services, Inc. has completed its compression molding plant in the Shanghai Zhangjiang High-Tech Industrial Development Zone Qingpu Park in China. The new 11,900-square-meter plant manufactures components for packaging injectable drugs, supplying customers primarily in China and the Asia-Pacific region. It’s adjacent to the company’s injection molding facility that was dedicated in September 2009. 
 
“West is experiencing an exciting period of growth in the Asia-Pacific region and we are proud to complete our second manufacturing facility in China,” said Donald E. Morel, Jr., West’s chairman and chief executive officer. “This facility will provide better service to our customers, offering shorter lead times for delivery of our world-class pharmaceutical packaging products and creating new, flexible capacity to meet the growing demands for our products in China and throughout the Asia-Pacific region. Our investment in this new facility demonstrates our commitment to and confidence in the China market.
 
In addition to the plants in Qingpu, West also has a factory in Singapore and sales offices in Australia, China, India and Singapore. The company’s first manufacturing facility in India is currently under construction.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters